Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871639/0/en/Terns-Pharmaceuticals-Announces-Data-from-Ongoing-Phase-1-Pharmacokinetic-Study-of-Allosteric-BCR-ABL-Inhibitor-TERN-701-in-Adult-Healthy-Volunteers-and-Highlights-Potential-for-Co.html
https://www.globenewswire.com/news-release/2024/04/10/2861103/0/en/Terns-Pharmaceuticals-Appoints-Melita-Sun-Jung-as-Chief-Business-Officer.html
https://www.globenewswire.com//news-release/2024/03/14/2846679/0/en/Terns-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Updates.html
https://www.globenewswire.com//news-release/2024/03/11/2844151/0/en/Terns-Pharmaceuticals-Announces-Orphan-Drug-Designation-Granted-to-TERN-701-for-the-Treatment-of-Chronic-Myeloid-Leukemia.html
https://www.globenewswire.com//news-release/2024/03/07/2842742/0/en/Terns-Pharmaceuticals-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-C-4.html
https://www.globenewswire.com//news-release/2024/02/27/2836430/0/en/Terns-Pharmaceuticals-to-Participate-in-Upcoming-March-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/07/2825557/0/en/Terns-Pharmaceuticals-Reports-Inducement-Grants-to-New-Chief-Executive-Officer-Under-Nasdaq-Listing-Rule-5635-C-4.html
https://www.globenewswire.com//news-release/2024/02/07/2825170/0/en/Terns-Pharmaceuticals-Appoints-Amy-Burroughs-as-Chief-Executive-Officer.html
https://www.globenewswire.com//news-release/2024/02/02/2823047/0/en/Terns-Pharmaceuticals-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-C-4.html
https://www.fiercebiotech.com/biotech/terns-bows-out-mash-race-reverts-back-phase-1-obesity-cancer-assets